Bone Biologics (BBLG) Amortizatization of Intangibles (2014 - 2018)
Bone Biologics (BBLG) reported Amortizatization of Intangibles of $26990.0 for Q3 2018, down 82.21% year-over-year from $151680.0 in Q3 2017, and down 82.79% quarter-over-quarter from $156872.0 in Q2 2018.
Bone Biologics (BBLG) Amortizatization of Intangibles (2014 - 2018) Analysis & Trends
Bone Biologics (BBLG) has 5 years of Amortizatization of Intangibles data on file, last reported at $26990.0 in Q3 2018.
- Amortizatization of Intangibles for Q3 2018 came in at $26990.0, down 82.21% year-over-year; the trailing twelve-month figure through Dec 2019 was $26990.0 (down 92.08% YoY), and the FY2018 annual result was $340735.0, down 89.76% from the prior year.
- Amortizatization of Intangibles declined to $26990.0 in Q3 2018 per BBLG's latest filing, from $156872.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.4 million in Q4 2016 and troughed at -$2.6 million in Q2 2015.
- A 5-year average of $31117.1 and a median of $135611.0 in 2015 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2015 and 2016: Amortizatization of Intangibles plunged 6072.13% in 2015, then soared 680.29% in 2016.
- A 5-year view of Amortizatization of Intangibles shows it stood at $73572.0 in 2014, then jumped by 136.36% to $173892.0 in 2015, then soared by 680.29% to $1.4 million in 2016, then decreased by 13.85% to $1.2 million in 2017, then tumbled by 97.69% to $26990.0 in 2018.
- Business Quant data shows BBLG's Amortizatization of Intangibles at $26990.0 in Q3 2018, $156872.0 in Q2 2018, and $156873.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Bone Biologics | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 26,990.00 |
| Sep 30, 2018 | 26,990.00 |
| Jun 30, 2018 | 156,872.00 |
| Jun 30, 2018 | 156,872.00 |
| Mar 31, 2018 | 156,873.00 |
| Mar 31, 2018 | 156,873.00 |
| Dec 31, 2017 | 1.17 Mn |
| Dec 31, 2017 | 1.17 Mn |
| Sep 30, 2017 | 151,680.00 |
| Sep 30, 2017 | 151,680.00 |
| Jun 30, 2017 | -859,521.00 |
| Jun 30, 2017 | -859,521.00 |
| Mar 31, 2017 | 520,508.00 |
| Mar 31, 2017 | 520,508.00 |
| Dec 31, 2016 | 1.36 Mn |
| Dec 31, 2016 | 1.36 Mn |
| Sep 30, 2016 | -404,480.00 |
| Sep 30, 2016 | -404,480.00 |
| Jun 30, 2016 | 151,680.00 |
| Jun 30, 2016 | 151,680.00 |